JP2005503336A - エネルギー恒常性の調節に関与する、タンパク質ジスルフィド異性化酵素およびａｂｃ輸送体の相同性タンパク質 - Google Patents

エネルギー恒常性の調節に関与する、タンパク質ジスルフィド異性化酵素およびａｂｃ輸送体の相同性タンパク質 Download PDF

Info

Publication number
JP2005503336A
JP2005503336A JP2002577862A JP2002577862A JP2005503336A JP 2005503336 A JP2005503336 A JP 2005503336A JP 2002577862 A JP2002577862 A JP 2002577862A JP 2002577862 A JP2002577862 A JP 2002577862A JP 2005503336 A JP2005503336 A JP 2005503336A
Authority
JP
Japan
Prior art keywords
nucleic acid
devg4
devg22
devg20
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002577862A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503336A5 (enExample
Inventor
オイレンベルク カールステン
ブレンナー ギュンター
チオゼック トーマス
ヘダー トーマス
シュトイヤーナーゲル アルント
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Develogen AG
Original Assignee
Develogen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Develogen AG filed Critical Develogen AG
Publication of JP2005503336A publication Critical patent/JP2005503336A/ja
Publication of JP2005503336A5 publication Critical patent/JP2005503336A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52—Isomerases (5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y503/00—Intramolecular oxidoreductases (5.3)
    • C12Y503/04—Intramolecular oxidoreductases (5.3) transposing S-S bonds (5.3.4)
    • C12Y503/04001—Protein disulfide-isomerase (5.3.4.1), i.e. disufide bond-forming enzyme
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
JP2002577862A 2001-04-02 2002-03-28 エネルギー恒常性の調節に関与する、タンパク質ジスルフィド異性化酵素およびａｂｃ輸送体の相同性タンパク質 Pending JP2005503336A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01108315 2001-04-02
EP01113419 2001-06-01
PCT/EP2002/003540 WO2002079238A2 (en) 2001-04-02 2002-03-28 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis

Publications (2)

Publication Number Publication Date
JP2005503336A true JP2005503336A (ja) 2005-02-03
JP2005503336A5 JP2005503336A5 (enExample) 2005-12-22

Family

ID=26076527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002577862A Pending JP2005503336A (ja) 2001-04-02 2002-03-28 エネルギー恒常性の調節に関与する、タンパク質ジスルフィド異性化酵素およびａｂｃ輸送体の相同性タンパク質

Country Status (6)

Country Link
US (3) US7211563B2 (enExample)
EP (1) EP1373495B1 (enExample)
JP (1) JP2005503336A (enExample)
AT (1) ATE422540T1 (enExample)
DE (1) DE60231110D1 (enExample)
WO (1) WO2002079238A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019521961A (ja) * 2016-05-10 2019-08-08 メディミューン，エルエルシー タンパク質ジスルフィド結合の還元の防止

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003278079A1 (en) * 2002-10-14 2004-05-04 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Proteins involved in the regulation of energy homeostasis
WO2005001092A2 (en) * 2003-05-20 2005-01-06 Wyeth Compositions and methods for diagnosing and treating cancers
KR20070052788A (ko) * 2004-08-13 2007-05-22 밀레니엄 파머슈티컬스 인코퍼레이티드 전립선암의 확인, 평가, 예방 및 요법을 위한 유전자,조성물, 키트 및 방법
WO2012155070A1 (en) * 2011-05-12 2012-11-15 Salk Institute For Biological Studies Modulation of lipid homeostatis, methods and compositions related thereto

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59813430D1 (de) 1997-07-24 2006-05-04 Ciba Sc Holding Ag Perylenhydrazidimide als Carbonylderivatisierungsreagenzien
WO2000005368A1 (en) * 1998-07-20 2000-02-03 Incyte Pharmaceuticals, Inc. Human calcium regulatory proteins
US6759238B1 (en) * 1999-03-31 2004-07-06 St. Jude Children's Research Hospital Multidrug resistance associated proteins and uses thereof
US6753314B1 (en) * 1999-04-01 2004-06-22 Curagen Corporation Protein-protein complexes and methods of using same
AU2001289864A1 (en) * 2000-09-08 2002-03-22 Bayer Aktiengesellschaft Regulation of human protein disulfide isomerase-like enzyme
US20050202421A1 (en) * 2001-10-31 2005-09-15 Raphael Hirsch Method for diagnosis and treatment of rheumatoid arthritis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019521961A (ja) * 2016-05-10 2019-08-08 メディミューン，エルエルシー タンパク質ジスルフィド結合の還元の防止
JP7170542B2 (ja) 2016-05-10 2022-11-14 メディミューン，エルエルシー タンパク質ジスルフィド結合の還元の防止
JP2023011805A (ja) * 2016-05-10 2023-01-24 メディミューン，エルエルシー タンパク質ジスルフィド結合の還元の防止
JP7514900B2 (ja) 2016-05-10 2024-07-11 メディミューン，エルエルシー タンパク質ジスルフィド結合の還元の防止

Also Published As

Publication number Publication date
DE60231110D1 (de) 2009-03-26
US20070185048A1 (en) 2007-08-09
US7211563B2 (en) 2007-05-01
WO2002079238A3 (en) 2003-09-04
US7404952B2 (en) 2008-07-29
US20080075713A1 (en) 2008-03-27
EP1373495A2 (en) 2004-01-02
WO2002079238A2 (en) 2002-10-10
US20040097457A1 (en) 2004-05-20
EP1373495B1 (en) 2009-02-11
ATE422540T1 (de) 2009-02-15

Similar Documents

Publication Publication Date Title
JP5185962B2 (ja) エネルギー恒常性および細胞小器官代謝の調節に関与するＭｎｋキナーゼ相同性タンパク質
JP2005508178A (ja) エネルギー恒常性の調節に関与するＭｅｎタンパク質、ＧＳＴ２、Ｒａｂ−ＲＰ１、Ｃｓｐ、Ｆ−ボックスタンパク質Ｌｉｌｉｎａ／ＦＢＬ７、ＡＢＣ５０、コロニン、Ｓｅｃ６１α、またはＶｈａＰＰＡ１−１、または相同性タンパク質
EP1373495B1 (en) Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
JP2005507398A (ja) エネルギー恒常性の調節に関与するＢｅｓｔｒｏｐｈｉｎおよびＢｅｓｔｒｏｐｈｉｎ相同性タンパク質
US20040242515A1 (en) Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis
JP2005511660A6 (ja) エネルギー恒常性の調節に関与する、ＰＴＰ１０Ｄ、Ｔｅｃタンパク質チロシンキナーゼおよびＥＤＴＰの相同性タンパク質
JP2005511660A (ja) エネルギー恒常性の調節に関与する、ＰＴＰ１０Ｄ、Ｔｅｃタンパク質チロシンキナーゼおよびＥＤＴＰの相同性タンパク質
JP2005507948A (ja) エネルギー恒常性の調節に関与するエンドフィリン相同性タンパク質
US20060168667A1 (en) Minibrain homologous proteins involved in the regulation of energy homeostasis
US20050233956A1 (en) Proteins involved in the regulation of energy homeostasis
AU2002308110A1 (en) Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis
JP2005505264A (ja) 新規ヒトプロトンゲート調節チャンネル
US20050119206A1 (en) Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
JP2005516608A (ja) エネルギー恒常性の調節に関与するキナーゼ
JP2006501290A (ja) エネルギー恒常性の調節に関与するＭｉｐｐ１相同性を有する核酸およびタンパク質
WO2004047855A2 (en) Proteins involved in the regulation of energy homeostasis
JP2006519757A (ja) エネルギー恒常性の調節に関与するタンパク質
WO2004064856A2 (en) Proteins involved in the regulation of energy homeostasis
JP2005519102A (ja) エネルギー恒常性の調節に関与するｃｇ３８４２相同タンパク質
JP2006500413A (ja) 代謝制御に関連するＳＫＲＰ、ａｓｔｒａｙ、ｓｔｒｉｎｇ、ＶＡＣＭ
WO2004002513A2 (en) Proteins involved in the regulation of energy homeostasis
WO2004050007A2 (en) Mammalian bt-42 proteins involved in the regulation of energy homeostasis
WO2003084566A2 (en) Proteins involved in the regulation of energy homeostasis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050314

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050314

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080612

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080910

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090213

RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20090312

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090312

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090511

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090518

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090611

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090618

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091006